Atlas Trials

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

Clinical trial NCT04890522 · NOT_YET_RECRUITING

Trial details

NCT number
NCT04890522
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal CarcinomaMetastasisChemotherapyImmunotherapySurvival
Start date
2021-07-01
Primary completion
2023-12-31
Enrollment
622

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.